Comparison · NSE · data 2026-11-02
Anthem Biosciences Limited vs Rubicon Research Limited
In plain words
Size: Anthem Biosciences Limited is about 1.8 times the market value of Rubicon Research Limited.
Valuation (P/E): Rubicon Research Limited 95.5 vs Anthem Biosciences Limited 81.7.
Return on equity: Rubicon Research Limited 27% vs Anthem Biosciences Limited 21.7%.
Debt to equity: Rubicon Research Limited 0.24 vs Anthem Biosciences Limited 0.02.
Differences in the numbers, not a recommendation of either stock.
Side by side
| ANTHEM | RUBICON | |
|---|---|---|
| Price | ₹829.2 | ₹1,657.4 |
| Market cap | ₹46,685 cr | ₹26,650 cr |
| P/E | 81.7 | 95.5 |
| P/B | — | — |
| ROE | 21.7% | 27.0% |
| ROCE | 26.0% | 32.4% |
| Debt / equity | 0.02 | 0.24 |
| Operating margin | 32.7% | 20.6% |
| Dividend yield | 0.24% | 0.09% |
| Sales growth, 3 years (yearly) | 26.2% | 64.7% |
| Profit growth, 3 years (yearly) | 15.4% | — |
| 1-year return | 15.9% | 169.8% |
| Revenue, last 12 months | ₹2,002 cr | ₹1,936 cr |
| Net profit, last 12 months | ₹576 cr | ₹288 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹120 cr | ₹85 cr |
| Quarter profit vs a year earlier | -11.7% | — |
| Promoter holding | 71.40% | 51.25% |
| Health check | Average (5.8/10) | Strong (7.1/10) |
Common questions
Which has a higher P/E, Anthem Biosciences Limited or Rubicon Research Limited?
Rubicon Research Limited trades at the higher P/E (95.5 against 81.7). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Rubicon Research Limited (27.0% against 21.7%).
Which carries more debt?
Rubicon Research Limited has the higher debt-to-equity ratio (0.24 against 0.02).